News
Character Biosciences has raised $93m in an oversubscribed Series B round to speed the clinical development of a pipeline of drugs for progressive vision disorders, starting with age-related ...
The obligatory beach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results